Literature DB >> 24574520

Autophagy and cancer therapy.

Andrew Thorburn1, Douglas H Thamm, Daniel L Gustafson.   

Abstract

Autophagy is the process by which cellular material is delivered to lysosomes for degradation and recycling. There are three different types of autophagy, but macroautophagy, which involves the formation of double membrane vesicles that engulf proteins and organelles that fuse with lysosomes, is by far the most studied and is thought to have important context-dependent roles in cancer development, progression, and treatment. The roles of autophagy in cancer treatment are complicated by two important discoveries over the past few years. First, most (perhaps all) anticancer drugs, as well as ionizing radiation, affect autophagy. In most, but not all cases, these treatments increase autophagy in tumor cells. Second, autophagy affects the ability of tumor cells to die after drug treatment, but the effect of autophagy may be to promote or inhibit cell death, depending on context. Here we discuss recent research related to autophagy and cancer therapy with a focus on how these processes may be manipulated to improve cancer therapy.

Entities:  

Mesh:

Year:  2014        PMID: 24574520      PMCID: PMC4014668          DOI: 10.1124/mol.114.091850

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  105 in total

1.  Autophagic degradation of active caspase-8: a crosstalk mechanism between autophagy and apoptosis.

Authors:  Wen Hou; Jie Han; Caisheng Lu; Leslie A Goldstein; Hannah Rabinowich
Journal:  Autophagy       Date:  2010-10-16       Impact factor: 16.016

Review 2.  Deconvoluting the context-dependent role for autophagy in cancer.

Authors:  Eileen White
Journal:  Nat Rev Cancer       Date:  2012-04-26       Impact factor: 60.716

3.  The vitamin E analogue α-TEA stimulates tumor autophagy and enhances antigen cross-presentation.

Authors:  Yuhuan Li; Tobias Hahn; Kendra Garrison; Zhi-Hua Cui; Andrew Thorburn; Jacqueline Thorburn; Hong-Ming Hu; Emmanuel T Akporiaye
Journal:  Cancer Res       Date:  2012-06-28       Impact factor: 12.701

4.  Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy?

Authors:  Molly L Bristol; Sean M Emery; Paola Maycotte; Andrew Thorburn; Shweta Chakradeo; David A Gewirtz
Journal:  J Pharmacol Exp Ther       Date:  2013-01-04       Impact factor: 4.030

Review 5.  Autophagy and aging.

Authors:  David C Rubinsztein; Guillermo Mariño; Guido Kroemer
Journal:  Cell       Date:  2011-09-02       Impact factor: 41.582

Review 6.  The anticancer immune response: indispensable for therapeutic success?

Authors:  Laurence Zitvogel; Lionel Apetoh; François Ghiringhelli; Fabrice André; Antoine Tesniere; Guido Kroemer
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

7.  Targeting autophagy addiction in cancer.

Authors:  Joseph D Mancias; Alec C Kimmelman
Journal:  Oncotarget       Date:  2011-12

8.  Autophagy variation within a cell population determines cell fate through selective degradation of Fap-1.

Authors:  Jacob M Gump; Leah Staskiewicz; Michael J Morgan; Alison Bamberg; David W H Riches; Andrew Thorburn
Journal:  Nat Cell Biol       Date:  2013-12-08       Impact factor: 28.824

9.  Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation.

Authors:  Jennifer S Carew; Ernest C Medina; Juan A Esquivel; Devalingam Mahalingam; Ronan Swords; Kevin Kelly; Hui Zhang; Peng Huang; Alain C Mita; Monica M Mita; Francis J Giles; Steffan T Nawrocki
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

10.  Autophagy inhibition promotes 5-fluorouraci-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells.

Authors:  Xiaohong Pan; Xiuli Zhang; Hongliu Sun; Jinjin Zhang; Miaomiao Yan; Huaibin Zhang
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

View more
  134 in total

1.  Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.

Authors:  Yang Su; Jingxiao Lu; Xianguo Chen; Chaozhao Liang; Pengcheng Luo; Cong Qin; Jie Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2018-12-03       Impact factor: 4.553

2.  RIP1 negatively regulates basal autophagic flux through TFEB to control sensitivity to apoptosis.

Authors:  Tohru Yonekawa; Graciela Gamez; Jihye Kim; Aik Choon Tan; Jackie Thorburn; Jacob Gump; Andrew Thorburn; Michael J Morgan
Journal:  EMBO Rep       Date:  2015-04-23       Impact factor: 8.807

3.  Tyrosine kinase receptor EGFR regulates the switch in cancer cells between cell survival and cell death induced by autophagy in hypoxia.

Authors:  Yongqiang Chen; Elizabeth S Henson; Wenyan Xiao; Daniel Huang; Eileen M McMillan-Ward; Sara J Israels; Spencer B Gibson
Journal:  Autophagy       Date:  2016-05-11       Impact factor: 16.016

4.  New compound ChlA-F induces autophagy-dependent anti-cancer effect via upregulating Sestrin-2 in human bladder cancer.

Authors:  Xiaohui Hua; Jiheng Xu; Xu Deng; Jiawei Xu; Jingxia Li; David Q Zhu; Junlan Zhu; Honglei Jin; Zhongxian Tian; Haishan Huang; Qin-Shi Zhao; Chuanshu Huang
Journal:  Cancer Lett       Date:  2018-08-16       Impact factor: 8.679

Review 5.  The molecular mechanisms between autophagy and apoptosis: potential role in central nervous system disorders.

Authors:  Hai-Jian Wu; Jia-Li Pu; Paul R Krafft; Jian-Min Zhang; Sheng Chen
Journal:  Cell Mol Neurobiol       Date:  2014-09-26       Impact factor: 5.046

Review 6.  Targeting autophagy in cancer.

Authors:  Jean M Mulcahy Levy; Christina G Towers; Andrew Thorburn
Journal:  Nat Rev Cancer       Date:  2017-07-28       Impact factor: 60.716

7.  Chloroquine supplementation increases the cytotoxic effect of curcumin against Her2/neu overexpressing breast cancer cells in vitro and in vivo in nude mice while counteracts it in immune competent mice.

Authors:  L Masuelli; M Granato; M Benvenuto; R Mattera; R Bernardini; M Mattei; G d'Amati; G D'Orazi; A Faggioni; R Bei; M Cirone
Journal:  Oncoimmunology       Date:  2017-07-31       Impact factor: 8.110

8.  The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel.

Authors:  Anne Monks; Yingdong Zhao; Curtis Hose; Hossein Hamed; Julia Krushkal; Jianwen Fang; Dmitriy Sonkin; Alida Palmisano; Eric C Polley; Laura K Fogli; Mariam M Konaté; Sarah B Miller; Melanie A Simpson; Andrea Regier Voth; Ming-Chung Li; Erik Harris; Xiaolin Wu; John W Connelly; Annamaria Rapisarda; Beverly A Teicher; Richard Simon; James H Doroshow
Journal:  Cancer Res       Date:  2018-10-24       Impact factor: 12.701

9.  Tracing the footsteps of autophagy in computational biology.

Authors:  Dipanka Tanu Sarmah; Nandadulal Bairagi; Samrat Chatterjee
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

10.  mda-7/IL-24 Mediates Cancer Cell-Specific Death via Regulation of miR-221 and the Beclin-1 Axis.

Authors:  Anjan K Pradhan; Sarmistha Talukdar; Praveen Bhoopathi; Xue-Ning Shen; Luni Emdad; Swadesh K Das; Devanand Sarkar; Paul B Fisher
Journal:  Cancer Res       Date:  2016-12-09       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.